Page last updated: 2024-08-21

alpha-aminopyridine and gsk-j4

alpha-aminopyridine has been researched along with gsk-j4 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bayo, J; Behrens, C; Bhanu, NV; Coombes, K; Dalvi, MP; Garcia, BA; Gazdar, AF; Girard, L; Heymach, JV; Kalhor, N; Kittler, R; Kollipara, RK; Martinez, ED; Minna, JD; Mino, B; Park, H; Parra, ER; Pataer, A; Rodriguez-Canales, J; Suraokar, M; Swisher, SG; Timmons, BC; Villalobos, P; Wang, L; Wistuba, II; Xie, Y; Yenerall, P; Zhong, R; Zhou, Y	1
Bayo, J; Das, AK; Martinez, ED; Peña-Llopis, S; Tran, TA; Wang, L	1

Other Studies

2 other study(ies) available for alpha-aminopyridine and gsk-j4

Article	Year
Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors. Cell reports, 2017, 05-23, Volume: 19, Issue:8 Topics: Aminopyridines; Animals; Antineoplastic Agents; Benzazepines; Bridged-Ring Compounds; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Disease-Free Survival; Drug Resistance, Neoplasm; Enzyme Inhibitors; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histones; Humans; Hydrazones; Jumonji Domain-Containing Histone Demethylases; Lung Neoplasms; Methylation; Mice; Neoadjuvant Therapy; Pyrimidines; Taxoids; Transcription, Genetic	2017
Jumonji Inhibitors Overcome Radioresistance in Cancer through Changes in H3K4 Methylation at Double-Strand Breaks. Cell reports, 2018, 10-23, Volume: 25, Issue:4 Topics: Aminopyridines; Animals; Benzazepines; Cell Line, Tumor; Demethylation; DNA Breaks, Double-Stranded; DNA Repair; DNA-Activated Protein Kinase; DNA-Binding Proteins; Female; Histones; Humans; Hydrazones; Jumonji Domain-Containing Histone Demethylases; Methylation; Mice, Nude; Nuclear Proteins; Pyrimidines; Rad51 Recombinase; Radiation Tolerance; Survival Analysis; Tumor Suppressor p53-Binding Protein 1	2018

Article

Year

Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors.

Cell reports, 2017, 05-23, Volume: 19, Issue:8

Topics: Aminopyridines; Animals; Antineoplastic Agents; Benzazepines; Bridged-Ring Compounds; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Disease-Free Survival; Drug Resistance, Neoplasm; Enzyme Inhibitors; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histones; Humans; Hydrazones; Jumonji Domain-Containing Histone Demethylases; Lung Neoplasms; Methylation; Mice; Neoadjuvant Therapy; Pyrimidines; Taxoids; Transcription, Genetic

2017

Jumonji Inhibitors Overcome Radioresistance in Cancer through Changes in H3K4 Methylation at Double-Strand Breaks.

Cell reports, 2018, 10-23, Volume: 25, Issue:4

Topics: Aminopyridines; Animals; Benzazepines; Cell Line, Tumor; Demethylation; DNA Breaks, Double-Stranded; DNA Repair; DNA-Activated Protein Kinase; DNA-Binding Proteins; Female; Histones; Humans; Hydrazones; Jumonji Domain-Containing Histone Demethylases; Methylation; Mice, Nude; Nuclear Proteins; Pyrimidines; Rad51 Recombinase; Radiation Tolerance; Survival Analysis; Tumor Suppressor p53-Binding Protein 1

2018